HC Wainwright & Co. Reiterates Buy on Mustang Bio, Maintains $25 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Joseph Pantginis reiterated a Buy rating on Mustang Bio (NASDAQ:MBIO) and maintained a $25 price target.
June 16, 2023 | 11:02 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Joseph Pantginis reiterated a Buy rating on Mustang Bio and maintained a $25 price target.
The reiteration of a Buy rating and maintenance of a $25 price target by HC Wainwright & Co. analyst Joseph Pantginis is a positive signal for Mustang Bio. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100